rs78923296
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000507955.6(DDX41):n.*1151C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000941 in 1,586,982 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0045 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00056 ( 11 hom. )
Consequence
DDX41
ENST00000507955.6 non_coding_transcript_exon
ENST00000507955.6 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.213
Publications
0 publications found
Genes affected
DDX41 (HGNC:18674): (DEAD-box helicase 41) DEAD box proteins, characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD), are putative RNA helicases. They are implicated in a number of cellular processes involving alteration of RNA secondary structure, such as translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. Based on their distribution patterns, some members of the DEAD box protein family are believed to be involved in embryogenesis, spermatogenesis, and cellular growth and division. The protein encoded by this gene is a member of the DEAD box protein family and interacts with several spliceosomal proteins. In addition, the encoded protein may recognize the bacterial second messengers cyclic di-GMP and cyclic di-AMP, resulting in the induction of genes involved in the innate immune response. [provided by RefSeq, Jan 2017]
DDX41 Gene-Disease associations (from GenCC):
- DDX41-related hematologic malignancy predisposition syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, ClinGen, Ambry Genetics
- acromesomelic dysplasiaInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 5-177511717-G-A is Benign according to our data. Variant chr5-177511717-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 434911.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00452 (688/152344) while in subpopulation AFR AF = 0.0158 (658/41574). AF 95% confidence interval is 0.0148. There are 2 homozygotes in GnomAd4. There are 337 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DDX41 | NM_016222.4 | c.*74C>T | 3_prime_UTR_variant | Exon 17 of 17 | ENST00000330503.12 | NP_057306.2 | ||
| DDX41 | NM_001321732.2 | c.*74C>T | 3_prime_UTR_variant | Exon 16 of 16 | NP_001308661.1 | |||
| DDX41 | NM_001321830.2 | c.*74C>T | 3_prime_UTR_variant | Exon 17 of 17 | NP_001308759.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00453 AC: 689AN: 152226Hom.: 2 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
689
AN:
152226
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000561 AC: 805AN: 1434638Hom.: 11 Cov.: 31 AF XY: 0.000470 AC XY: 334AN XY: 710552 show subpopulations
GnomAD4 exome
AF:
AC:
805
AN:
1434638
Hom.:
Cov.:
31
AF XY:
AC XY:
334
AN XY:
710552
show subpopulations
African (AFR)
AF:
AC:
659
AN:
33068
American (AMR)
AF:
AC:
44
AN:
43910
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
24916
East Asian (EAS)
AF:
AC:
0
AN:
39284
South Asian (SAS)
AF:
AC:
6
AN:
83906
European-Finnish (FIN)
AF:
AC:
0
AN:
52260
Middle Eastern (MID)
AF:
AC:
3
AN:
5658
European-Non Finnish (NFE)
AF:
AC:
17
AN:
1092458
Other (OTH)
AF:
AC:
76
AN:
59178
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
42
83
125
166
208
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00452 AC: 688AN: 152344Hom.: 2 Cov.: 33 AF XY: 0.00452 AC XY: 337AN XY: 74500 show subpopulations
GnomAD4 genome
AF:
AC:
688
AN:
152344
Hom.:
Cov.:
33
AF XY:
AC XY:
337
AN XY:
74500
show subpopulations
African (AFR)
AF:
AC:
658
AN:
41574
American (AMR)
AF:
AC:
20
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5192
South Asian (SAS)
AF:
AC:
3
AN:
4826
European-Finnish (FIN)
AF:
AC:
0
AN:
10632
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1
AN:
68022
Other (OTH)
AF:
AC:
6
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
37
73
110
146
183
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jun 21, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
Jul 06, 2017
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.